These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1678600

  • 1. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
    Humphrey PA, Gangarosa LM, Wong AJ, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum OD, Friedman HS, Bigner DD.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):1413-20. PubMed ID: 1678600
    [Abstract] [Full Text] [Related]

  • 2. The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.
    Pandit SD, Donis-Keller H, Iwamoto T, Tomich JM, Pike LJ.
    J Biol Chem; 1996 Mar 08; 271(10):5850-8. PubMed ID: 8621456
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
    Katayama H, Hashimoto Y, Kiyokawa E, Nakaya M, Sakamoto A, Machinami R, Kurata T, Mochizuki N, Matsuda M.
    Jpn J Cancer Res; 1999 Oct 08; 90(10):1096-103. PubMed ID: 10595738
    [Abstract] [Full Text] [Related]

  • 4. A chimeric EGFR/neu receptor in studies of neu function.
    Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K.
    Cancer Treat Res; 1992 Oct 08; 61():213-28. PubMed ID: 1360234
    [No Abstract] [Full Text] [Related]

  • 5. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2.
    Di Fiore PP, Helin K, Kraus MH, Pierce JH, Artrip J, Segatto O, Bottaro DP.
    EMBO J; 1992 Nov 08; 11(11):3927-33. PubMed ID: 1356764
    [Abstract] [Full Text] [Related]

  • 6. The epidermal growth factor receptor and its ligands.
    Wells A.
    Cancer Treat Res; 1989 Nov 08; 47():143-68. PubMed ID: 2576995
    [No Abstract] [Full Text] [Related]

  • 7. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI.
    Proc Natl Acad Sci U S A; 1988 Aug 08; 85(15):5389-93. PubMed ID: 2899889
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo.
    Ezeh PI, Farbman AI.
    J Neurobiol; 1998 Nov 05; 37(2):199-210. PubMed ID: 9805267
    [Abstract] [Full Text] [Related]

  • 10. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling.
    Moriai T, Kobrin MS, Hope C, Speck L, Korc M.
    Proc Natl Acad Sci U S A; 1994 Oct 11; 91(21):10217-21. PubMed ID: 7937865
    [Abstract] [Full Text] [Related]

  • 11. Amplified cellular oncogenes in neoplasms of the human central nervous system.
    Fuller GN, Bigner SH.
    Mutat Res; 1992 May 11; 276(3):299-306. PubMed ID: 1374522
    [Abstract] [Full Text] [Related]

  • 12. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H, Lehtola L, Sistonen L, Alitalo K.
    EMBO J; 1989 Jan 11; 8(1):159-66. PubMed ID: 2565807
    [Abstract] [Full Text] [Related]

  • 13. Structural alterations of the epidermal growth factor receptor gene in human gliomas.
    Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):2965-9. PubMed ID: 1557402
    [Abstract] [Full Text] [Related]

  • 14. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM, Debanne MT, Grothe S, Bergsma D, Caron M, Kay C, O'Connor-McCourt MD.
    Eur J Biochem; 1994 Oct 01; 225(1):223-33. PubMed ID: 7925442
    [Abstract] [Full Text] [Related]

  • 15. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
    Shu HK, Pelley RJ, Kung HJ.
    Proc Natl Acad Sci U S A; 1990 Dec 01; 87(23):9103-7. PubMed ID: 1979168
    [Abstract] [Full Text] [Related]

  • 16. The type 1 (EGFR-related) family of growth factor receptors and their ligands.
    Prigent SA, Lemoine NR.
    Prog Growth Factor Res; 1992 Dec 01; 4(1):1-24. PubMed ID: 1355372
    [Abstract] [Full Text] [Related]

  • 17. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF, Heffernan PA, Weinberg RA.
    Mol Cell Biol; 1986 May 01; 6(5):1729-40. PubMed ID: 2878363
    [Abstract] [Full Text] [Related]

  • 18. Receptor functions and ligand-dependent transforming potential of a chimeric kit proto-oncogene.
    Lev S, Yarden Y, Givol D.
    Mol Cell Biol; 1990 Nov 01; 10(11):6064-8. PubMed ID: 1700279
    [Abstract] [Full Text] [Related]

  • 19. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Wada T, Qian XL, Greene MI.
    Cell; 1990 Jun 29; 61(7):1339-47. PubMed ID: 1973074
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
    Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2900-4. PubMed ID: 8464905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.